PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2026-01-21

Date Title Company
21-Jan-2026 Wareham Development Leases Full Floor at EmeryStation Research Campus to CytomX Therapeutics Businesswire
21-Jan-2026 Best Practices for Supplier Qualification in Life Science: Online Training Course (May 6th-7th, 2026) with 12 CPD Hours - ResearchAndMarkets.com Businesswire
21-Jan-2026 Pharmaceutical Regulatory Affairs in Africa Online Training Course (May 6th-7th, 2026) with 12 CPD Hours - ResearchAndMarkets.com Businesswire
21-Jan-2026 Medical Device Regulations in the Middle East and North Africa: Online Training Course (May 18th-19th, 2026) - ResearchAndMarkets.com Businesswire
21-Jan-2026 Understanding Active Pharmaceutical Ingredients (APIs): Online Training Course (Apr 29-30, 2026) - Enhance Your API Expertise with In-Depth GMP and GDP Training - ResearchAndMarkets.com Businesswire
21-Jan-2026 Cough Syrup Market Forecast 2026-2032: Total Revenues to Exceed $7.57 Billion by 2032 - ResearchAndMarkets.com Businesswire
21-Jan-2026 INTENT Biologics Receives FDA Agreement Granting a Full Waiver for its Pediatric Study Plan for PEP Biologic™ in Advanced Wound Care Businesswire
21-Jan-2026 Antihistamine Drugs Market | Global Forecast 2026-2032 | Revenues to Grow by $1.41 Billion - ResearchAndMarkets.com Businesswire
21-Jan-2026 KOMO Biosciences Appoints Patient Advocate Tom Whitehead and Immunotherapy Pioneer Michael Kalos, Ph.D. to Advisory Board Businesswire
21-Jan-2026 Onco-Innovations Engages i2i Marketing Group Engagement for Market Awareness Services ACCESS Newswire
21-Jan-2026 Biocom Announces Powerhouse Keynote Panel Featuring Heads of Discovery and Research & Development from AbbVie, Amgen and Eli Lilly at 2026 Global Partnering & Investor Conference Businesswire
21-Jan-2026 Outcome Capital Expands Pharmacy and Related Services Board to Enhance Strategic Advisory Capabilities and Drive Value Creation Businesswire
21-Jan-2026 Opna Bio Announces Orphan Drug Designation Granted to OPN-2853 (Zavabresib) for the Treatment of Myelofibrosis Businesswire
21-Jan-2026 Orca Bio to Present New Clinical Data on Its High-Precision Cell Therapies at the 2026 Tandem Meetings of ASTCT® and CIBMTR® Businesswire
21-Jan-2026 Zura Bio Appoints Immunology Industry Leader Sandeep Kulkarni, M.D. as Chief Executive Officer Businesswire
21-Jan-2026 Vetter Achieves Top Sustainability Rating and Expands Climate Goal Commitments Businesswire
21-Jan-2026 Charles River Enters Manufacturing Collaboration with Gazi University Businesswire
21-Jan-2026 Odyssey Therapeutics Appoints Jolie M. Siegel as Executive Vice President, General Counsel Businesswire
21-Jan-2026 U.S. FDA Grants to Wugen’s WU-CART-007 Breakthrough Therapy Designation for Treatment of Relapsed or Refractory T Cell Acute Lymphoblastic Leukemia / T Cell Lymphoblastic Lymphoma Businesswire
21-Jan-2026 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire